Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SILTUXIMAB Cause Cytokine release syndrome? 26 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Cytokine release syndrome have been filed in association with SILTUXIMAB (Sylvant). This represents 5.5% of all adverse event reports for SILTUXIMAB.

26
Reports of Cytokine release syndrome with SILTUXIMAB
5.5%
of all SILTUXIMAB reports
18
Deaths
9
Hospitalizations

How Dangerous Is Cytokine release syndrome From SILTUXIMAB?

Of the 26 reports, 18 (69.2%) resulted in death, 9 (34.6%) required hospitalization, and 3 (11.5%) were considered life-threatening.

Is Cytokine release syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SILTUXIMAB. However, 26 reports have been filed with the FAERS database.

What Other Side Effects Does SILTUXIMAB Cause?

Off label use (96) Drug ineffective (72) Disease progression (32) Immune effector cell-associated neurotoxicity syndrome (28) Death (27) Hypertension (24) Product use in unapproved indication (24) Drug effective for unapproved indication (23) Cataract (19) Condition aggravated (19)

What Other Drugs Cause Cytokine release syndrome?

AXICABTAGENE CILOLEUCEL (4,140) CYCLOPHOSPHAMIDE (2,263) TISAGENLECLEUCEL (1,660) FLUDARABINE (1,458) RITUXIMAB (1,404) BLINATUMOMAB (952) DEXAMETHASONE (853) DOXORUBICIN (850) BREXUCABTAGENE AUTOLEUCEL (827) VINCRISTINE (771)

Which SILTUXIMAB Alternatives Have Lower Cytokine release syndrome Risk?

SILTUXIMAB vs SILVER SULFADIAZINE SILTUXIMAB vs SIMEPREVIR SILTUXIMAB vs SIMPONI SILTUXIMAB vs SIMVASTATIN SILTUXIMAB vs SINGULAIR

Related Pages

SILTUXIMAB Full Profile All Cytokine release syndrome Reports All Drugs Causing Cytokine release syndrome SILTUXIMAB Demographics